BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37240772)

  • 1. In Silico Subtractive Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against
    Shami A; Alharbi NK; Al-Saeed FA; Alsaegh AA; Al Syaad KM; Abd El-Rahim IHA; Mostafa YS; Ahmed AE
    Life (Basel); 2023 May; 13(5):. PubMed ID: 37240772
    [No Abstract]   [Full Text] [Related]  

  • 2. Subtractive genomics and molecular docking approach to identify drug targets against Stenotrophomonas maltophilia.
    Saleem H; Ashfaq UA; Nadeem H; Zubair M; Siddique MH; Rasul I
    PLoS One; 2021; 16(12):e0261111. PubMed ID: 34910751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of molecular docking and molecular dynamics simulations with subtractive proteomics approach to identify the novel drug targets and their inhibitors in Streptococcus gallolyticus.
    Chao P; Zhang X; Zhang L; Yang A; Wang Y; Chen X
    Sci Rep; 2024 Jun; 14(1):14755. PubMed ID: 38926437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Core Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against
    Rehman A; Wang X; Ahmad S; Shahid F; Aslam S; Ashfaq UA; Alrumaihi F; Qasim M; Hashem A; Al-Hazzani AA; Abd Allah EF
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769873
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Duguma T; Dinka H
    Biomed Res Int; 2024; 2024():5917667. PubMed ID: 38283072
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential Therapeutic Candidates against
    Kadi RH; Altammar KA; Hassan MM; Shater AF; Saleh FM; Gattan H; Al-Ahmadi BM; AlGabbani Q; Mohammedsaleh ZM
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742569
    [No Abstract]   [Full Text] [Related]  

  • 7. Proteome Exploration of
    Khan MT; Mahmud A; Hasan M; Azim KF; Begum MK; Rolin MH; Akter A; Mondal SI
    Microbiol Spectr; 2022 Aug; 10(4):e0037322. PubMed ID: 35863001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18.
    Rahman N; Muhammad I; Nayab GE; Khan H; Filosa R; Xiao J; Hassan STS
    Curr Top Med Chem; 2019; 19(29):2708-2717. PubMed ID: 31702501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtractive genome analysis for in silico identification and characterization of novel drug targets in Streptococcus pneumonia strain JJA.
    Wadood A; Jamal A; Riaz M; Khan A; Uddin R; Jelani M; Azam SS
    Microb Pathog; 2018 Feb; 115():194-198. PubMed ID: 29277475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K; Khan W; Azam SS; Wadood A
    Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against
    Hossain T; Kamruzzaman M; Choudhury TZ; Mahmood HN; Nabi AHMN; Hosen MI
    Biomed Res Int; 2017; 2017():3783714. PubMed ID: 28904956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mining the Proteome of Streptococcus mutans for Putative Drug Targets.
    Marimuthu SCV; Ravinarayanan H; Rosy JC; Sundar K
    Infect Disord Drug Targets; 2021; 21(3):429-438. PubMed ID: 32568025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtractive proteomics approach to Unravel the druggable proteins of the emerging pathogen
    Chowdhury UF; Saba AA; Sufi AS; Khan AM; Sharmin I; Sultana A; Islam MO
    Heliyon; 2021 Jun; 7(6):e07320. PubMed ID: 34195427
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of a subtractive genomics approach for in silico identification and characterization of novel drug targets in Mycobacterium tuberculosis F11.
    Hosen MI; Tanmoy AM; Mahbuba DA; Salma U; Nazim M; Islam MT; Akhteruzzaman S
    Interdiscip Sci; 2014 Mar; 6(1):48-56. PubMed ID: 24464704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of repurposable drug targets in
    Chowdhury ZM; Jamal TB; Ahammad I; Bhattacharjee A; Lamisa AB; Jani JM; Israk MF; Hossain MU; Das KC; Keya CA; Salimullah M
    Heliyon; 2023 Nov; 9(11):e21466. PubMed ID: 38034688
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative Metabolic Pathways Analysis and Subtractive Genomics Profiling to Prioritize Potential Drug Targets Against
    Khan K; Jalal K; Khan A; Al-Harrasi A; Uddin R
    Front Microbiol; 2021; 12():796363. PubMed ID: 35222301
    [No Abstract]   [Full Text] [Related]  

  • 17. Genome-Based Drug Target Identification in Human Pathogen
    Qureshi NA; Bakhtiar SM; Faheem M; Shah M; Bari A; Mahmood HM; Sohaib M; Mothana RA; Ullah R; Jamal SB
    Front Genet; 2021; 12():564056. PubMed ID: 33841489
    [No Abstract]   [Full Text] [Related]  

  • 18. A computational subtractive genome analysis for the characterization of novel drug targets in Klebsiella pneumonia strain PittNDM01.
    Rafiq H; Ullah K; Ahmad B; Rehman AU; Shah MK; Khan A; Uddin R; Azam SS; Wadood A
    Microb Pathog; 2020 Sep; 146():104245. PubMed ID: 32423883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Pangenome Analysis and Pharmacophore Modeling Revealed Potential Novel Inhibitors against
    Almuhayawi MS; Al Jaouni SK; Selim S; Alkhalifah DHM; Marc RA; Aslam S; Poczai P
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.